As the season of influenza and influenza-like illnesses (ILI) is here, it’s time to get your lab ready with the QIAstat-Dx Respiratory Panel. It’s the only multiplex respiratory panel that provides Ct values for 21 bacterial and viral targets, as well as an error-proof workflow for greater ease of use and reduced risk of contamination. Get in touch with us today to learn how QIAstat-Dx can improve your lab’s services to patients and clinicians.
A recent report from the Australian Department of Health has indicated high flu activity early in their flu season (1).
Download the infographic to see which strains are expected to dominate this year, as well as new data on the Australian flu season.
Watch this video clip with Dr. Benoit Visseaux and Dr. Celestin Alexis Agbessi discussing how syndromic testing makes a difference in testing for respiratory illnesses in an emergency room setting.
Our specialists are ready to answer your questions about QIAstat-Dx. Please provide us with your contact information and we will get in touch with you soon.
We have received your request and will get back to you soon.
In the meantime, please feel free to visit QIAstat-Dx.com to find out more about QIAstat-Dx, learn about its panels, watch webinars and more.
Your QIAstat-Dx team
The QIAstat-Dx Analyzer and the QIAstat-Dx Respiratory Panel are intended for in vitro diagnostic use.
1. Australian Government Department of Health. (2019) Australian Influenza Surveillance Report. Number 5, June 17–30.